Best approach for low-risk superficial bladder cancer.
In order to create better criteria for different grades of superficial bladder tumor, the WHO and ISUOP develop a new classification in 1998, which was modified in 2004. Although the new classification might be more reproducible, it has not yet been widely accepted. The low risk groups include patients with single Ta, G1, < or = 3 cm diameter tumors. This group has high recurrence and low progression rates. The standard treatment is the complete resection and postoperative single immediate instillation of whatever chemotherapy agent should be considered.
Solsona
Eduardo
E
Service of Urology, Instituto Valenciano de Oncologia, Valencia, Spain. solsona@pulso.com
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D018450:Disease Progression; D006801:Humans; D008495:Medical Oncology / Q000379:methods*; D012306:Risk; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000145:classification* / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D014572:Urology / Q000379:methods*
D000970:Antineoplastic Agents